The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors

Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma

(2013) Smita K. Baid   ANNALS OF INTERNAL MEDICINE

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

(2010) Samuel A. Wells et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased Urinary Excretion of 3-Methoxytyramine in Patients with Head and Neck Paragangliomas

(2009) N. van Duinen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer

(2009) Martin J. Schlumberger et al.   JOURNAL OF CLINICAL ONCOLOGY

Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells

(2008) David Yu Greenblatt et al.   ANNALS OF SURGERY

Suberoyl Bishydroxamic Acid Activates Notch1 Signaling and Suppresses Tumor Progression in an Animal Model of Medullary Thyroid Carcinoma

(2008) Li Ning et al.   ANNALS OF SURGICAL ONCOLOGY

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation

(2008) Kunwar S. S. Bhatia et al.   CLINICAL ENDOCRINOLOGY

Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

(2008) Steven I. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Management of Medullary Thyroid Cancer

(2008) R. S. Sippel et al.   ONCOLOGIST